ClassID:

96750

C07K7/52 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring

Recent Application in this class:
#1
20260053886
2026-02-26

ANTICANCER AGENT

#2
20250250299
2025-08-07

MACROCYCLIC IMMUNOMODULATORS

#3
20250026790
2025-01-23

BOTULINUM NEUROTOXIN-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

#4
20240360178
2024-10-31

MACROCYCLIC IMMUNOMODULATORS

#5
20240309048
2024-09-19

METHOD FOR PREPARING MICROCOCCIN-BASED CARBOXYLIC ACID COMPOUND AND MICROCOCCIN-BASED CARBOXYLIC ACID COMPOUND PREPARED THEREBY

#6
20240299591
2024-09-12

Antimicrobial Peptides and Their Use

#7
20240299566
2024-09-12

POLY-ARGININE DERIVATIVES FOR ENHANCING BRAIN-DERIVED GROWTH FACTOR TO MITIGATE NEUROLOGICAL DISORDERS

#8
20240182524
2024-06-06

Cyclic peptidomimetic for the treatment of neurological disorders

#9
20240150403
2024-05-09

TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

#10
20240148569
2024-05-09

ABSORBENT STRUCTURE FOR ABSORBENT ARTICLES

#11
20230406884
2023-12-21

Cyclic peptides multimers targeting α4β7 integrin

#12
20230083431
2023-03-16

MACROCYCLIC PEPTIDES AS POTENT INHIBITORS OF K-RAS G12D MUTANT

#13
20220267378
2022-08-25

PEPTIDES AS INHIBITORS OF FIBROTIC MATRIX ACCUMULATION

#14
20220265487
2022-08-25

Absorbent structure for absorbent articles

#15
20220251141
2022-08-11

IMMUNOMODULATORS

#16
20220194986
2022-06-23

Cyclic peptidomimetic for the treatment of neurological disorders

#17
20220177512
2022-06-09

CYCLIC PEPTIDE PRODUCTION METHOD

#18
20210369807
2021-12-02

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#19
20210324007
2021-10-21

Cyclic peptides multimers targeting α-4-β-7 integrin

#20
20210107944
2021-04-15

COMPSTATIN ANALOGS FOR TREATMENT OF NEUROPATHIC PAIN

#21
20210101935
2021-04-08

CYCLIC PEPTIDOMIMETIC FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#22
20200216501
2020-07-09

Cyclic peptides multimers targeting alpha-4-beta-7 integrin

#23
20190365849
2019-12-05

Absorbent structure for absorbent articles

#24
20190359676
2019-11-28

Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders

#25
20190185515
2019-06-20

Compstatin analogs for treatment of neuropathic pain

#26
20190056393
2019-02-21

METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT

#27
20180118786
2018-05-03

NOVEL lNHIBITORS OF THE ENZYME ACTIVATED FACTOR XII (FXIIA)

#28
20170340698
2017-11-30

CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF

#29
20170269078
2017-09-21

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit

#30
20170218021
2017-08-03

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#31
20170204134
2017-07-20

Cyclising peptides

#32
20170166610
2017-06-15

Compstatin Analogs for Treatment of Neuropathic Pain

#33
20160356723
2016-12-08

Light-Up Probes Based On Fluorogens With Aggregation Induced Emission Characteristics For Cellular Imaging And Drug Screening

#34
20160331800
2016-11-17

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#35
20160222074
2016-08-04

Alpha-fetoprotein “ring and tail” peptides

#36
20160185823
2016-06-30

Antimicrobial polymyxins for treatment of bacterial infections

#37
20160175386
2016-06-23

Immunomodulators

#38
20160130304
2016-05-12

Cyclosporin analogues for preventing or treating hepatitis C infection

#39
20160122391
2016-05-05

Short beta-defensin-derived peptides

#40
20160051625
2016-02-25

Cyclosporin analogues for preventing or treating hepatitis C infection

#41
20140336069
2014-11-13

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#42
20140179708
2014-06-26

Substituted piperazin-2,5-diones as multifunctional bioactive compounds

#43
20140121168
2014-05-01

ANTAGONISTS OF TRPV1 RECEPTOR

#44
20130267677
2013-10-10

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#45
20130183267
2013-07-18

Cyclosporin analogues for preventing or treating hepatitis C infection

#46
20130059794
2013-03-07

Alpha-fetoprotein “ring and tail” peptides

#47
20120316526
2012-12-13

Absorbent structure for absorbent articles

#48
20120045411
2012-02-23

Short beta-defensin-derived peptides

#49
20110195861
2011-08-11

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#50
20100196316
2010-08-05

Cyclosporin analogues for preventing or treating hepatitis C infection

#51
20100048586
2010-02-25

Substituted piperazin-2,5-diones and their use as multifunctional bioactive compounds

#52
20080033003
2008-02-07

Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents

#53
20070287665
2007-12-13

Urotensin-II agonists and antagonists

#54
20070207502
2007-09-06

Cell comprising an intein for the production of a cyclic peptide

#55
20070087380
2007-04-19

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#56
20050118100
2005-06-02

Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent

#57
20050075480
2005-04-07

Urotensin-II agonists and antagonists